Pfizer Ireland, which has a huge facility in Cork, and its German partner BioNTech say they may be able to dispense around 100 million doses of their experimental vaccine.
Ireland is on the list of countries that could get it if the vaccine is approved first by the U.S. Food and Drug Administration and then by the European Emergency Medicines Agency.
If all goes well, these processes should be completed in a few weeks.
However, it is believed that FDA approval will not be obtained until after the US presidential election.
The two-dose vaccine BNT162b2 has been tested on 35,000 people to date, with a total of 39,862 people participating in the study program.
Paul Reid, Managing Director of Pfizer Ireland said, “We can have 100 million cans by the end of 2020. If we have a pre-sale agreement with the EU Commission, this is guaranteed. Part of it would contain a volume that we believe we can make available across Europe.
“We are accelerating the clinical study program at breakneck speed. We’re seeing a rate of recruitment in the studies that we’ve never seen before. ”
Speaking to the Irish Independent, he added, “The FDA will review the data with its own scientists. It is reviewed by an external body of independent experts at a public meeting. We need to prove the quality and consistency of the vaccine.
“We try to be as open as possible. We share any meaningful positive or negative readings within a few days of being seen by independent scientists. The positive attitude towards the vaccine has so far been based on good scientific knowledge. ”
With Pfizer at the forefront of finding a viable vaccine, the company could make billions.
According to Fiercepharma.com, analysts at SVB Leerink estimate that the vaccine will “hit a high of $ 3.5 billion next year before declining to around $ 1.4 billion a year thereafter”.
They believe those who take the vaccine need to be vaccinated again every two years “to maintain protective immunity”.
They believe the vaccine is consumed by “about 80%” of health care workers and high-risk adults, including the elderly and people with chronic illnesses.
SVB Leerink also estimates that the price of the vaccine will be $ 30 per dose in the US and $ 23 overseas.
These were the details of the news The Covid-19 vaccine could be in Ireland before the end of... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at de24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
